https://pipelinereview.com/index.php/2020110276376/Small-Molecules/Tetra-Therapeutics-Announces-Positive-Topline-Results-from-Phase-2-Study-of-BPN14770-in-Patients-with-Fragile-X-Syndrome.html
Interesting. And well worth a read. What they have achieved is amazing. Possibly building bridges. But unlike Xanamem, they are targeting the nervous system, which could be very complicating when it comes to other medications. (AED) anti- epileptic drugs. etc...
- Forums
- ASX - By Stock
- ACW
- Ann: ACW to initiate XanaFX clinical trial in Fragile X syndrome
Ann: ACW to initiate XanaFX clinical trial in Fragile X syndrome, page-9
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.08M |
Open | High | Low | Value | Volume |
2.4¢ | 2.5¢ | 2.1¢ | $526.7K | 22.84M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 431842 | 2.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 499979 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 344886 | 0.023 |
8 | 2367558 | 0.022 |
8 | 1493218 | 0.021 |
23 | 3169396 | 0.020 |
7 | 2536684 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 499979 | 1 |
0.025 | 2793761 | 6 |
0.026 | 3070150 | 9 |
0.027 | 1612009 | 5 |
0.028 | 675157 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online